{"References": [{"title": "Fibroblast growth factor 21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic, pharmacokinetic, and safety profiles", "authors": "Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "Biotechnology and Bioengineering", "year": "2018", "volumes": "115", "first page": "1565", "last page": "1575", "DOI": "10.1002/bit.26578"}, {"title": "The role of fibroblast growth factor 21 in the pathogenesis of obesity and its associated metabolic complications", "authors": "Yanyun Chen, Xiaoying He, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "Endocrine Reviews", "year": "2017", "volumes": "38", "first page": "1", "last page": "20", "DOI": "10.1210/er.2016-1107"}, {"title": "Fibroblast growth factor 21 as a therapeutic agent for metabolic diseases", "authors": "Yanyan Li, Xiaoying He, Yanyun Chen, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "BioDrugs", "year": "2018", "volumes": "32", "first page": "201", "last page": "212", "DOI": "10.1007/s40259-018-0279-0"}, {"title": "Therapeutic potential of FGF21 in metabolic diseases: from bench to clinic", "authors": "Yanyan Wang, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "Nature Reviews Endocrinology", "year": "2016", "volumes": "12", "first page": "603", "last page": "610", "DOI": "10.1038/nrendo.2016.72"}, {"title": "Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic applications in obesity/type 2 diabetes mellitus", "authors": "Yanyan Zhang, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "International Journal of Obesity", "year": "2017", "volumes": "41", "first page": "1641", "last page": "1650", "DOI": "10.1038/ijo.2017.168"}, {"title": "FGF21-based pharmacotherapyâ€”potential utility for metabolic disorders", "authors": "Yanyan Liu, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "Trends in Endocrinology & Metabolism", "year": "2018", "volumes": "29", "first page": "389", "last page": "399", "DOI": "10.1016/j.tem.2018.03.001"}, {"title": "Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease", "authors": "Yanyan Zhao, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Sun, Yanyan Xu", "journal": "Current Opinion in Clinical Nutrition & Metabolic Care", "year": "2017", "volumes": "20", "first page": "138", "last page": "145", "DOI": "10.1097/MCO.0000000000000353"}, {"title": "Therapeutic implications of FGF21 in the treatment of diabetes", "authors": "Yanyan Sun, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Xu", "journal": "Pharmacology & Therapeutics", "year": "2018", "volumes": "185", "first page": "1", "last page": "10", "DOI": "10.1016/j.pharmthera.2017.10.004"}, {"title": "Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic applications in obesity/type 2 diabetes mellitus", "authors": "Yanyan Xu, Xiaoying He, Yanyun Chen, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun", "journal": "Journal of Diabetes Research", "year": "2017", "volumes": "2017", "first page": "1", "last page": "10", "DOI": "10.1155/2017/3185874"}, {"title": "Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic applications in obesity/type 2 diabetes mellitus", "authors": "Yanyan Chen, Xiaoying He, Yanyan Li, Yanyan Wang, Yanyan Zhang, Yanyan Liu, Yanyan Zhao, Yanyan Sun, Yanyan Xu", "journal": "Frontiers in Endocrinology", "year": "2018", "volumes": "9", "first page": "1", "last page": "10", "DOI": "10.3389/fendo.2018.00001"}]}